WORK Medical Technology Group
1 hedge funds and large institutions have $244 invested in WORK Medical Technology Group in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less funds holding
Funds holding: 2 → 1 (-1)
96% less capital invested
Capital invested by funds: $5.75K → $244 (-$5.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.31K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $240 | – | – | – |
|
|
CIAM
2
Caitong International Asset Management
Hong Kong
| $4 | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$5.31K | -24 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$2 | – | – |
|
WOK Hedge Fund Activity: Q1 2026 in Review
1 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in WORK Medical Technology Group (WOK) for Q1 2026, worth a combined $244 — down 96% from $5.75K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of WOK and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $5.31K sold.
- 1 institutional investor held WORK Medical Technology Group (WOK) as of Q1 2026, down from 2 in Q4 2025.
- Funds reported $244 of WORK Medical Technology Group stock for Q1 2026, down 96% quarter-over-quarter.
- 0 funds opened new WORK Medical Technology Group positions in Q1 2026 and 1 closed out, a net change of -1 holder.
- The largest WORK Medical Technology Group seller in Q1 2026 was UBS Group, an estimated $5.31K sold.
Based on aggregated 13F filings for Q1 2026.